Patent Number: 6,169,084

Title: 2-methyl-thieno-benzodiazepine formulation

Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.

Inventors: Bunnell; Charles Arthur (Lafayette, IN), Ferguson; Thomas Harry (Greenfield, IN), Hendriksen; Barry Arnold (Guildford, GB), Sanchez-Felix; Manuel Vicente (Grayshott, GB), Tupper; David Edward (Reading, GB)

Assignee: Eli Lilly and Company

International Classification: A61K 47/00 (20060101); A61K 31/551 (20060101); C07D 495/00 (20060101); A61K 9/16 (20060101); C07D 495/04 (20060101); A61K 47/36 (20060101); A61K 47/26 (20060101); A61K 47/38 (20060101); A61K 47/22 (20060101); A61K 47/28 (20060101); A61K 47/10 (20060101); A61K 47/14 (20060101); A61K 47/24 (20060101); A61K 47/32 (20060101); A61K 031/55 (); A61P 025/18 (); C07D 243/10 ()

Expiration Date: 01/02/2018